Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety
- 16 August 1998
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (4) , 40J-46J
- https://doi.org/10.1016/s0002-9149(98)00436-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitorAtherosclerosis, 1997
- 127 Pharmacokinetics of single dose cerivastatin in subjects with normal and impaired renal functionAtherosclerosis, 1997
- 109 Lack of pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxinAtherosclerosis, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- No Pharmacokinetic or Pharmacodynamic Interaction Between Rivastatin and WarfarinThe Journal of Clinical Pharmacology, 1995
- BAY W 6228Drugs of the Future, 1994
- Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.British Journal of Clinical Pharmacology, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- Efficacy and safety of pravastatin in patients with primary hypercholesterolemiaAtherosclerosis, 1990